Qi Liu

The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.

H. Ouyang, Shen-Zhen Ren, Weiwei Ni, 2018, Bioorganic & medicinal chemistry.

Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.

Shen-Zhen Ren, Hui Chen, Weiwei Ni, 2018, European journal of medicinal chemistry.

3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.

Hong-yu Zhang, Peng-Fei Wang, Meini Yang, 2016, Bioorganic & medicinal chemistry.

High‐throughput tandem‐microwell assay for ammonia repositions FDA‐Approved drugs to inhibit Helicobacter pylori urease

F. Liu, L. Liao, Jinyi Xu, 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

High-throughput tandem-microwell assay for ammonia repositions FDA-Approved drugs to Helicobacter pylori infection

L. Liao, Jinyi Xu, Houqin Fang, 2021, bioRxiv.

Resolution and evaluation of 3‐chlorophenyl‐3‐hydroxypropionylhydroxamic acid as antivirulence agent with excellent eradication efficacy in Helicobacter pylori infected mice

Weiwei Ni, Yong Pei, Zhu-Ping Xiao, 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

C-7 modified flavonoids as novel tyrosyl-tRNA synthetase inhibitors

Peng-Fei Wang, Honglan Huang, Wei Wei, 2017 .

Synthesis and evaluation of adenosine containing 3-arylfuran-2(5H)-ones as tyrosyl-tRNA synthetase inhibitors.

Wei Wei, Zhu-Ping Xiao, Jia Liu, 2017, European journal of medicinal chemistry.